Health Care [ 10/12 ] | Health Care Providers & Services [ 35/73 ]
NASDAQ | Common Stock
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus.
The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names.
It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin).
In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand.
It serves wholesalers and retail healthcare providers.
Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 18, 25 | -0.10 Increased by +9.09% | 0.01 Decreased by -1.10 K% |
| Apr 15, 25 | -0.41 Increased by +75.86% | -0.08 Decreased by -412.50% |
| Nov 14, 24 | -0.45 Decreased by -68.35% | -0.11 Decreased by -309.09% |
| Aug 19, 24 | -0.15 Decreased by -65.38% | -0.14 Decreased by -7.14% |
| Apr 12, 24 | -0.11 Increased by +98.54% | -0.14 Increased by +21.43% |
| Dec 31, 23 | -1.70 Increased by +55.50% | -0.20 Decreased by -749.10% |
| Nov 20, 23 | -0.27 Decreased by -234.12% | - |
| Aug 15, 23 | -0.09 Increased by +90.25% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 14.75 M Increased by +11.65% | -2.83 M Decreased by -9.16% | Decreased by -19.18% Increased by +2.23% |
| Mar 31, 25 | 13.71 M Decreased by -5.98% | -818.10 K Increased by +56.17% | Decreased by -5.97% Increased by +53.39% |
| Dec 31, 24 | 14.22 M Decreased by -10.20% | -9.54 M Increased by +30.61% | Decreased by -67.09% Increased by +22.72% |
| Sep 30, 24 | 12.41 M Decreased by -3.22% | -2.18 M Increased by +34.83% | Decreased by -17.59% Increased by +32.67% |
| Jun 30, 24 | 13.21 M Increased by +6.82% | -2.59 M Decreased by -163.95% | Decreased by -19.62% Decreased by -147.09% |
| Mar 31, 24 | 14.58 M Increased by +18.10% | -1.87 M Decreased by -305.92% | Decreased by -12.80% Decreased by -243.73% |
| Dec 31, 23 | 15.84 M Increased by +31.44% | -13.75 M Decreased by -27.10% | Decreased by -86.82% Increased by +3.30% |
| Sep 30, 23 | 12.82 M Increased by +6.72% | -3.35 M Decreased by -69.77% | Decreased by -26.12% Decreased by -59.08% |